High dosage doramectin formulation

Details for Australian Patent Application No. 2010233409 (hide)

Owner Pfizer Inc.

Inventors Costa, Alvimar Jose; Secreast, Stephen Lee; Valarelli, Rodrigo

Agent Allens Patent & Trade Mark Attorneys

Pub. Number AU-B-2010233409

PCT Pub. Number WO2010/116267

Priority 61/219,837 24.06.09 US; 61/152,911 16.02.09 US

Filing date 2 February 2010

Wipo publication date 14 October 2010

Acceptance publication date 17 May 2012

International Classifications

A61K 31/7048 (2006.01)

A61K 9/00 (2006.01) Medicinal preparations characterised by special physical form

A61K 45/06 (2006.01) Medicinal preparations containing active ingredients not provided for in groups

A61P 33/10 (2006.01) Antiparasitic agents

Event Publications

11 August 2011 PCT application entered the National Phase

  PCT publication WO2010/116267 Priority application(s): WO2010/116267

17 May 2012 Application Accepted

  Published as AU-B-2010233409

13 September 2012 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2010233417-System and method for providing feedback to a subject regarding reception of positive airway support therapy

2010233406-Safening agent